Results 151 to 160 of about 90,634 (287)

Involvement of α-galactosidase OmAGAL2 in planteose hydrolysis during seed germination of Orobanche minor. [PDF]

J Exp Bot, 2022
Okazawa A, Baba A, Okano H, Tokunaga T, Nakaue T, Ogawa T, Shimma S, Sugimoto Y, Ohta D.   +8 more
europepmc   +1 more source

Efficient synthesis of α‐galactosyl oligosaccharides using a mutant Bacteroides thetaiotaomicron retaining α‐galactosidase (BtGH97b) [PDF]

, 2017
Masayuki Okuyama, Kana Matsunaga, Kenichi Watanabe, Keitaro Yamashita, Takayoshi Tagami, Asako Kikuchi, Min Ma, Patcharapa Klahan, Haruhide Mori, Min Yao, Atsuo Kimura   +10 more
openalex   +1 more source

Oat β‐Glucan and Galactooligosaccharides Influence Gallstone Formation by Modulating the Gut Microbiota, Particularly Desulfovibrionales

iMetaMed, EarlyView.
Oat β‐glucan and galactooligosaccharides influence the formation of gallstones by modulating the gut microbiota, particularly the abundance of Desulfovibrionales. The primary mechanism involves metabolic byproducts associated with Desulfovibrionales inhibiting hepatic bile acid synthesis via both the hepatic FXR–SHP and intestinal FXR–FGF15 signaling ...
Liang Tian, Yanyan Lin, Ping Yue, Long Gao, Leiqing Wang, Chongfei Huang, Jinyu Zhao, Ningzu Jiang, Jiahui xi, Haidong Ma, Zhen Liu, Ruyang Zhong, Wenkang Fu, Ningning Mi, Mingzhen Bai, Bodong Zhang, Lunzhi Dai, Jiang Li, Hu Chen, Jinqiu Yuan, Wenbo Meng   +20 more
wiley   +1 more source

Targeting Microbiome Metabolites: Reshaping Immunotherapy and Clinical Management Strategies for Colorectal Cancer

iMetaMed, EarlyView.
The occurrence and progression of colorectal cancer are intricately linked to metabolites produced by the gut microbiota. Metabolites generated by pathogenic microbial communities can promote colorectal cancer development by reshaping the immune microenvironment.
Xinrui Yang, Ke Zhang, Lijie Xia, Jinyao Li   +3 more
wiley   +1 more source

Fabry Cardiomyopathy: Myocardial Fibrosis, Inflammation, and Down‐Regulation of Mannose‐6‐Phosphate Receptors Cause Low Accessibility to Enzyme Replacement Therapy

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background The clinical impact of enzyme replacement therapy on advanced Fabry disease cardiomyopathy appears to be limited. The pathologic mechanisms involved are still unclear.
Andrea Frustaci, Romina Verardo, Michele Magnocavallo, Emanuela Frustaci, Matteo Antonio Russo, Cristina Chimenti   +5 more
doaj   +1 more source

Heterologous Expression of a Thermostable α-Galactosidase from Parageobacillus thermoglucosidasius Isolated from the Lignocellulolytic Microbial Consortium TMC7. [PDF]

J Microbiol Biotechnol, 2022
Wang Y, Wang C, Chen Y, Cui M, Wang Q, Guo P.   +5 more
europepmc   +1 more source

Local and global cerebral blood flow and glucose utilization in the α‐galactosidase A knockout mouse model of Fabry disease [PDF]

, 2001
Yoshiaki Itoh, Takanori Esaki, Michelle Cook, Pankaj Qasba, Kazuaki Shimoji, Joseph Alroy, Roscoe O. Brady, Louis Sokoloff, David F. Moore   +8 more
openalex   +1 more source

Heart failure in two male patients with late‐onset Fabry mutation (IVS4 + 919G > A)

ESC Heart Failure, Volume 12, Issue 2, Page 1508-1513, April 2025.
Xufei Yang, Chunlan Deng, Xiaogang Guo, Hui Yan   +3 more
wiley   +1 more source

Novel α-galactosidase A gene mutation in a Chinese Fabry disease family: A case report. [PDF]

World J Clin Cases, 2022
Fu AY, Jin QZ, Sun YX.
europepmc   +1 more source

Polyglutamine-expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMA. [PDF]

, 2014
Macroautophagy (hereafter autophagy) is a key pathway in neurodegeneration. Despite protective actions, autophagy may contribute to neuron demise when dysregulated.
Batlevi, Yakup, Carromeu, Cassiano, Cortes, Constanza J, Frankowski, Harald, Garden, Gwenn A, Ivanov, Nishi, La Spada, Albert R, Le, Amy, Miranda, Helen C, Muotri, Alysson R, Sopher, Bryce L, Young, Jessica E   +11 more
core